Financials Seyitler Kimya Sanayi
Equities
SEYKM
TRESEYT00011
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.51 TRY | +3.93% |
|
+1.17% | +67.14% |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 61.6 | 108.6 | 552 | 410.8 | 676.1 | 569 |
Enterprise Value (EV) 1 | 60.79 | 103.2 | 536.9 | 377.9 | 613.1 | 524.4 |
P/E ratio | 23.4 x | 22.6 x | 27.3 x | 30.4 x | 9.47 x | -8.13 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 2.57 x | 3.29 x | 10.4 x | 6.82 x | 6.09 x | 2.9 x |
EV / Revenue | 2.53 x | 3.12 x | 10.1 x | 6.28 x | 5.52 x | 2.68 x |
EV / EBITDA | 17.3 x | 21.6 x | 54.4 x | 37.7 x | 20 x | 37.8 x |
EV / FCF | -105 x | 107 x | -68.5 x | -241 x | -21 x | -93.6 x |
FCF Yield | -0.95% | 0.94% | -1.46% | -0.41% | -4.77% | -1.07% |
Price to Book | 2.7 x | 3.93 x | 11.5 x | 5.69 x | 4.71 x | 2.48 x |
Nbr of stocks (in thousands) | 100,001 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 |
Reference price 2 | 0.6160 | 1.086 | 5.520 | 4.108 | 6.761 | 5.690 |
Announcement Date | 2/28/19 | 2/20/20 | 2/23/21 | 2/28/22 | 2/24/23 | 5/8/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 24.01 | 33.04 | 52.9 | 60.19 | 111 | 196.1 |
EBITDA 1 | 3.505 | 4.785 | 9.871 | 10.03 | 30.6 | 13.86 |
EBIT 1 | 2.628 | 3.987 | 8.757 | 8.399 | 28.62 | 4.716 |
Operating Margin | 10.94% | 12.07% | 16.55% | 13.95% | 25.78% | 2.41% |
Earnings before Tax (EBT) 1 | 3.388 | 5.652 | 20.25 | 24.53 | 79.35 | -70.2 |
Net income 1 | 2.63 | 4.805 | 20.2 | 24.34 | 71.43 | -69.81 |
Net margin | 10.95% | 14.54% | 38.18% | 40.43% | 64.36% | -35.61% |
EPS 2 | 0.0263 | 0.0480 | 0.2020 | 0.1353 | 0.7143 | -0.7000 |
Free Cash Flow 1 | -0.577 | 0.9688 | -7.833 | -1.567 | -29.26 | -5.606 |
FCF margin | -2.4% | 2.93% | -14.81% | -2.6% | -26.36% | -2.86% |
FCF Conversion (EBITDA) | - | 20.25% | - | - | - | - |
FCF Conversion (Net income) | - | 20.16% | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 2/28/19 | 2/20/20 | 2/23/21 | 2/28/22 | 2/24/23 | 5/8/24 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - |
Net Cash position 1 | 0.81 | 5.46 | 15.1 | 32.9 | 63 | 44.6 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow 1 | -0.58 | 0.97 | -7.83 | -1.57 | -29.3 | -5.61 |
ROE (net income / shareholders' equity) | 12.2% | 19% | 53.5% | 40.5% | 66.2% | -27.3% |
ROA (Net income/ Total Assets) | 6.71% | 7.87% | 10% | 6.3% | 12.2% | 0.89% |
Assets 1 | 39.21 | 61.05 | 201.1 | 386.3 | 586.7 | -7,865 |
Book Value Per Share 2 | 0.2300 | 0.2800 | 0.4800 | 0.7200 | 1.440 | 2.290 |
Cash Flow per Share 2 | 0.0100 | 0.0200 | 0.0500 | 0.1800 | 0.3300 | 0.1000 |
Capex 1 | 0.48 | 1.89 | 5.62 | 5.41 | 2.87 | 31.5 |
Capex / Sales | 2% | 5.72% | 10.62% | 8.99% | 2.59% | 16.05% |
Announcement Date | 2/28/19 | 2/20/20 | 2/23/21 | 2/28/22 | 2/24/23 | 5/8/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+67.14% | 29.11M | |
+9.92% | 27.7B | |
+25.93% | 2.46B | |
+18.11% | 2.46B | |
-49.80% | 2.24B | |
-31.22% | 2.06B | |
+32.22% | 2.02B | |
-21.57% | 1.65B | |
+9.03% | 1.36B | |
+32.97% | 1.33B |
- Stock Market
- Equities
- SEYKM Stock
- Financials Seyitler Kimya Sanayi